1 – 23 of 23
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews
(
- Contribution to journal › Article
-
Mark
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis : The UPSIDE study protocol
(
- Contribution to journal › Article
- 2020
-
Mark
Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis
(
- Contribution to journal › Article
-
Mark
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study
(
- Contribution to journal › Article
-
Mark
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
(
- Contribution to journal › Article
- 2017
-
Mark
The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease : A multicentre European Scleroderma Trials and Research group (EUSTAR) study
(
- Contribution to journal › Article
-
Mark
Treatment outcome in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study (ESOS)
(
- Contribution to journal › Article
- 2016
-
Mark
Brief Report : IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
(
- Contribution to journal › Article
- 2013
-
Mark
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study
(
- Contribution to journal › Article
-
Mark
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
(
- Contribution to journal › Article
- 2012
-
Mark
KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor
(
- Contribution to journal › Article
-
Mark
A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations
(
- Contribution to journal › Article
-
Mark
Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis.
2012) In Journal of Rheumatology(
- Contribution to journal › Article
- 2011
-
Mark
The Functional Polymorphism 844 A>G in Fc{alpha}RI (CD89) Does Not Contribute to Systemic Sclerosis or Rheumatoid Arthritis Susceptibility.
(
- Contribution to journal › Article
-
Mark
Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis
(
- Contribution to journal › Letter
-
Mark
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.
(
- Contribution to journal › Article
-
Mark
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
(
- Contribution to journal › Article
-
Mark
Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy
(
- Contribution to journal › Article
- 2010
-
Mark
Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Study (EUSTAR).
(
- Contribution to journal › Article
-
Mark
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
(
- Contribution to journal › Article
- 2009
-
Mark
Distinct Temporal Evolution of TLR-mediated Dendritic Cell Cytokine Secretion in Patients with Limitied and Diffuse Cutaneous Systemic Sclerosis
2009) 9th Annual Meeting of the Federation-of-Clinical-Immunology-Societies In Clinical Immunology 131. p.153-154(
- Contribution to journal › Published meeting abstract